https://www.fiercebiotech.com/biotech/amgen-stops-trial-teneobio-cancer-candidate-taking-650m-bite-out-its-earnings
https://investors.amgen.com/news-releases/news-release-details/amgen-presents-new-cardiovascular-research-aha-2023
https://investor.lilly.com/news-releases/news-release-details/lilly-announces-details-pirtobrutinib-presentations-b-cell
https://investor.lilly.com/news-releases/news-release-details/lilly-declares-fourth-quarter-2023-dividend
https://investor.lilly.com/news-releases/news-release-details/hip-hop-classic-it-takes-two-takes-new-meaning-remix-elevate
https://investor.lilly.com/news-releases/news-release-details/lilly-reports-third-quarter-2023-financial-results-highlights
https://investor.lilly.com/news-releases/news-release-details/hip-hop-classic-it-takes-two-takes-new-meaning-remix-elevate
https://investor.lilly.com/news-releases/news-release-details/lilly-reports-third-quarter-2023-financial-results-highlights
https://investor.lilly.com/news-releases/news-release-details/lilly-announces-details-pirtobrutinib-presentations-b-cell
https://investor.lilly.com/news-releases/news-release-details/lilly-declares-fourth-quarter-2023-dividend
https://investor.lilly.com/news-releases/news-release-details/hip-hop-classic-it-takes-two-takes-new-meaning-remix-elevate
https://investor.lilly.com/news-releases/news-release-details/lilly-announces-details-pirtobrutinib-presentations-b-cell
https://investor.lilly.com/news-releases/news-release-details/lilly-declares-fourth-quarter-2023-dividend
https://investor.lilly.com/news-releases/news-release-details/lilly-reports-third-quarter-2023-financial-results-highlights
